Guardant Health, Nuvalent Partner in Precision Oncology
Palo Alto, USA | April 30, 2026 Guardant Health and Nuvalent have announced a multi-year strategic collaboration to develop...
Precision Oncology
Advertisement
CareDx Acquires Naveris to Expand Precision Oncology
BRISBANE, CALIFORNIA, April 28, 2026 CareDx Inc. has announced a definitive agreement to acquire Naveris, marking a significant expansion...
MediciNova Advances Brain Metastasis Therapy With MN-166
LA JOLLA, Calif., April 27, 2026 MediciNova, Inc. has announced a major scientific breakthrough in the treatment of brain...
IDEAYA Biosciences Darovasertib Combo Advances Uveal Melanoma Care
South San Francisco, California, USA, April 21, 2026 In a significant advancement in precision oncology, IDEAYA Biosciences, Inc. has...
Tempus AI, Predicta Expand Genomics Test for Blood Cancer
Chicago, Illinois, U.S. | April 15, 2026 Tempus AI, Inc., in collaboration with Predicta Biosciences, has announced the expansion...
Advertisements
Personalis Advances ctDNA Cancer Monitoring with AI Platform
Fremont, California | April 13, 2026 Personalis, Inc. has unveiled new data showcasing its ultrasensitive ctDNA-based cancer monitoring platform,...
GSK Reports Strong ADC Data in Ovarian Cancer Study
London, United Kingdom | April 13, 2026 GSK plc has announced positive clinical data from its Phase 1 BEHOLD-1...
Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers
Tel Aviv, Israel & Tokyo, Japan | April 9, 2026 Imagene AI has announced a strategic collaboration with Daiichi...
Telix NDA Accepted for Pixclara Brain Cancer Imaging
Melbourne, Australia & Indianapolis, USA | April 10, 2026 Telix Pharmaceuticals has announced that the U.S. Food and Drug...
Adagene Reports Strong Muzastotug KEYTRUDA CRC Data
San Diego, USA & Suzhou, China, April 2, 2026 Strong Clinical Efficacy in MSS Colorectal Cancer In a major...
Advertisement
